John Wiley & Sons, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2024
June 13, 2024 at 04:08 pm
Share
John Wiley & Sons, Inc. reported earnings results for the fourth quarter and full year ended April 30, 2024. For the fourth quarter, the company reported sales was USD 468.46 million compared to USD 526.13 million a year ago. Net income was USD 25.27 million compared to USD 68.34 million a year ago. Basic earnings per share from continuing operations was USD 0.46 compared to USD 1.23 a year ago. Diluted earnings per share from continuing operations was USD 0.46 compared to USD 1.22 a year ago.
For the full year, sales was USD 1,872.99 million compared to USD 2,019.9 million a year ago. Net loss was USD 200.32 million compared to net income of USD 17.23 million a year ago. Basic loss per share from continuing operations was USD 3.65 compared to basic earnings per share from continuing operations of USD 0.31 a year ago. Diluted loss per share from continuing operations was USD 3.65 compared to diluted earnings per share from continuing operations of USD 0.31 a year ago.
John Wiley & Sons, Inc. is a publisher. The Company's content, services, platforms, and knowledge networks are tailored to meet the needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. Its segments include Research, Learning and Held for Sale or Sold. Research segment provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Its journal publishing categories include the social sciences and humanities, and life sciences. Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. Its operations are located in the United States, United Kingdom, India, Sri Lanka, and Germany.